We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-2.62%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$4.84B
AUM Growth
-$154M
Cap. Flow
+$25M
Cap. Flow %
0.52%
Top 10 Hldgs %
18.29%
Holding
1,493
New
82
Increased
580
Reduced
615
Closed
118

Sector Composition

Rank Sector Weight
1 Technology 18.65%
2 Financials 10.44%
3 Healthcare 9.35%
4 Industrials 8.91%
5 Consumer Discretionary 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWP icon
251
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$4.49M 0.09%
49,181
-3,256
-6% -$311K
IWM icon
252
iShares Russell 2000 ETF
IWM
$81.5B
$4.47M 0.09%
25,287
+444
+2% +$83.4K
VXF icon
253
Vanguard Extended Market ETF
VXF
$31.8B
$4.46M 0.09%
31,123
-136
-0.4% -$20.4K
KTOS icon
254
Kratos Defense & Security Solutions
KTOS
$11.7B
$4.45M 0.09%
296,088
+242,047
+448% +$3.6M
WFG icon
255
West Fraser Timber
WFG
$5.58B
$4.44M 0.09%
61,267
+9,397
+18% +$739K
WBD icon
256
Warner Bros
WBD
$67.4B
$4.44M 0.09%
409,018
+53,909
+15% +$673K
SNA icon
257
Snap-on
SNA
$21.3B
$4.43M 0.09%
17,372
+775
+5% +$209K
BF.B icon
258
Brown-Forman Class B
BF.B
$12.9B
$4.41M 0.09%
76,453
+1
+0% +$67
GLW icon
259
Corning
GLW
$136B
$4.37M 0.09%
143,449
-1,385
-1% -$45.3K
KVUE icon
260
Kenvue
KVUE
$36.5B
$4.34M 0.09%
+216,320
New +$5.01M
XBI icon
261
State Street SPDR S&P Biotech ETF
XBI
$10.4B
$4.34M 0.09%
59,481
-9,982
-14% -$797K
BABA icon
262
Alibaba
BABA
$317B
$4.34M 0.09%
50,032
-3,172
-6% -$290K
HSY icon
263
Hershey
HSY
$36.7B
$4.24M 0.09%
21,171
+2,975
+16% +$666K
DXCM icon
264
DexCom
DXCM
$33.1B
$4.22M 0.09%
45,218
-518
-1% -$58.4K
VCIT icon
265
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.5B
$4.21M 0.09%
55,412
+1,819
+3% +$142K
BSX icon
266
Boston Scientific
BSX
$73.1B
$4.21M 0.09%
79,735
+41,836
+110% +$2.19M
CALF icon
267
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.87B
$4.19M 0.09%
100,403
+5,233
+5% +$221K
USFR icon
268
WisdomTree Floating Rate Treasury Fund
USFR
$18.4B
$4.17M 0.09%
82,841
+70,105
+550% +$3.53M
RSP icon
269
Invesco S&P 500 Equal Weight ETF
RSP
$99.1B
$4.17M 0.09%
29,413
-6,219
-17% -$929K
PLD icon
270
Prologis
PLD
$132B
$4.14M 0.09%
36,915
+11,095
+43% +$1.36M
ON icon
271
ON Semiconductor
ON
$31.1B
$4.13M 0.09%
44,393
-1,053
-2% -$102K
CRWD icon
272
CrowdStrike
CRWD
$229B
$4.12M 0.09%
98,448
+1,704
+2% +$66.2K
RDVY icon
273
First Trust Rising Dividend Achievers ETF
RDVY
$25.5B
$4.06M 0.08%
88,415
-7,595
-8% -$363K
EEM icon
274
iShares MSCI Emerging Markets ETF
EEM
$29.8B
$4.05M 0.08%
106,785
+10,068
+10% +$399K
DVY icon
275
iShares Select Dividend ETF
DVY
$23.6B
$4.05M 0.08%
37,591
-10,725
-22% -$1.22M

Similar funds

Oppenheimer & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Oppenheimer & Co held 1,493 positions worth $4.84B, down 3.1% from $5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q3 2023 filing shows 82 new, 580 increased, 615 reduced and 118 closed positions. Its largest new stake was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M. The largest sale was FT Vest US Equity Deep Buffer ETF December, an estimated $15.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2023 buy was FT Vest US Equity Deep Buffer ETF August: 562,231 shares worth $18.6M.
  • Oppenheimer & Co added most to ConocoPhillips in Q3 2023, an estimated $4.53M increase.
  • Oppenheimer & Co's biggest Q3 2023 reduction was Equitrans Midstream Corporation Common Stock, cutting an estimated $7.88M.
  • Oppenheimer & Co fully exited FT Vest US Equity Deep Buffer ETF December in Q3 2023, selling an estimated $15.1M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $4.84B portfolio in Q3 2023.
  • Oppenheimer & Co opened 82 new positions and closed 118 in Q3 2023.
  • Oppenheimer & Co's portfolio value fell 3.1% quarter-over-quarter to $4.84B.

Based on Oppenheimer & Co's 13F filing for Q3 2023, filed 8 Nov 2023.